Schizophrenia treatment showdown: monthly shot vs. daily pill
NCT ID NCT05165316
Summary
This study aims to find out if long-acting injectable medications help people with schizophrenia stay on treatment better than daily oral pills. It follows 400 patients who were in a previous study, tracking them for 19 months to see which treatment leads to fewer hospital stays and better daily functioning. The goal is to improve long-term management of schizophrenia by comparing two types of injectable medications against two types of oral medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tel Hashomer The Sheba Medical Center
Ramat Gan, Israel
Conditions
Explore the condition pages connected to this study.